Amfetamine extended-release - Neos TherapeuticsAlternative Names: Amphetamine XR-liquid suspension; Amphetamine XR-suspension - Neos Therapeutics; Extended release amphetamine liquid suspension - Neos Therapeutics; NT-0201
Latest Information Update: 21 Nov 2016
At a glance
- Originator Neos Therapeutics
- Class Amphetamines; Small molecules
- Mechanism of Action Adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Attention-deficit hyperactivity disorder